-
公开(公告)号：US20050164362A1
公开(公告)日：2005-07-28
申请号：US10872770
申请日：2004-06-21
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Megan Domagala , Simon Houston , Matthew Kimber , Benjamin Pinder , Francois Vallee , Olga Wrezel , Donald Awrey , Bryan Beattie
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Megan Domagala , Simon Houston , Matthew Kimber , Benjamin Pinder , Francois Vallee , Olga Wrezel , Donald Awrey , Bryan Beattie
CPC分类号： C12N9/18 , C07K14/21 , C07K2299/00
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
-
公开(公告)号：US20050239186A1
公开(公告)日：2005-10-27
申请号：US11047365
申请日：2005-01-31
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Matthew Kimber
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Matthew Kimber
CPC分类号： C12Q1/18 , C07K2299/00 , C07K2319/00 , C12N9/18 , C12Q1/34 , G01N2333/315 , G01N2333/918 , G01N2500/04
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20060003432A1
公开(公告)日：2006-01-05
申请号：US11047383
申请日：2005-01-31
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Teresa Clarke , Matthew Kimber
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Bryan Beattie , Teresa Clarke , Matthew Kimber
CPC分类号： C12N9/93 , C07K2299/00 , C12Q1/18 , C12Q1/25 , G01N2500/00
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20050181388A1
公开(公告)日：2005-08-18
申请号：US10958216
申请日：2004-10-04
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Veronica Canadien , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Benjamin Pinder , Dawn Richards , Matthew Tai , Rosanne Thalakada , Francois Vallee , Cristina Virag
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Muhammad Alam , Cheryl Arrowsmith , Donald Awrey , Bryan Beattie , Kristina Buzadzija , Veronica Canadien , Megan Domagala , Simon Houston , Dhushy Kanagarajah , Qin Li , Kamran Mansoury , Merry-Lynn McDonald , Kathleen Nethery-Brokx , Ivy Ng , Hui Ouyang , Benjamin Pinder , Dawn Richards , Matthew Tai , Rosanne Thalakada , Francois Vallee , Cristina Virag
IPC分类号： C07K14/245 , C07K14/315 , C07K14/32 , C12N9/00 , C12N9/02 , C12N9/04 , C12N9/10 , C12N9/12 , C12N9/14 , C12N9/16 , C12N9/78 , C12N9/90 , C12Q1/68 , G01N33/00
CPC分类号： C12N9/0008 , C07K14/245 , C07K14/3156 , C07K14/32 , C07K2319/00 , C12N9/0006 , C12N9/1007 , C12N9/1077 , C12N9/1085 , C12N9/1205 , C12N9/1229 , C12N9/1235 , C12N9/1241 , C12N9/14 , C12N9/16 , C12N9/78 , C12N9/90 , C12N9/93 , C12Y101/01158 , C12Y102/01011 , C12Y201/01033 , C12Y201/01045 , C12Y201/01061 , C12Y204/02007 , C12Y205/01007 , C12Y207/01026 , C12Y207/01048 , C12Y207/04008 , C12Y207/06001 , C12Y207/07003 , C12Y207/07023 , C12Y207/07038 , C12Y304/11018 , C12Y304/24057 , C12Y305/04005 , C12Y306/01001 , C12Y501/03001 , C12Y504/02003 , C12Y599/01003 , C12Y601/01014 , C12Y601/0102 , C12Y601/01021 , C12Y603/02004 , C12Y603/02008 , C12Y603/02013 , C12Y603/04014 , C12Y604/01002
摘要： The present invention relates to polypeptide targets for pathogenic bacteria. The invention also provides biochemical and biophysical characteristics of those polypeptides.
-
公开(公告)号：US20070004020A1
公开(公告)日：2007-01-04
申请号：US11172433
申请日：2005-06-30
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Robert Lam
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Robert Lam
CPC分类号： C12N9/0008 , C07K2299/00 , Y02A90/26
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20060079669A1
公开(公告)日：2006-04-13
申请号：US11171495
申请日：2005-06-30
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Robert Lam
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Robert Lam
CPC分类号： C12N9/93 , C07K2299/00 , G16B15/00 , Y02A90/26
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20050221462A1
公开(公告)日：2005-10-06
申请号：US10965006
申请日：2004-10-14
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Megan Domagala , Matthew Kimber , Francois Vallee
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Megan Domagala , Matthew Kimber , Francois Vallee
CPC分类号： C12N9/88 , C07K2299/00 , C12Q1/18 , G16B15/00 , G16B20/00
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20050245728A1
公开(公告)日：2005-11-03
申请号：US10967671
申请日：2004-10-18
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Francois Vallee
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Matthew Kimber , Francois Vallee
CPC分类号： C12N9/1085 , C07K2299/00 , C12Q1/18 , G01N2333/21
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20050187718A1
公开(公告)日：2005-08-25
申请号：US10922802
申请日：2004-08-20
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Teresa Clarke , Matthew Kimber , Vivek Sharma , Simon Houston , Kamran Mansoury
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Teresa Clarke , Matthew Kimber , Vivek Sharma , Simon Houston , Kamran Mansoury
IPC分类号： A61K38/00 , C07K14/205 , C07K14/21 , C07K14/245 , C07K14/31 , C07K14/315 , C12N9/00 , C12N9/04 , C12N9/10 , C12N9/12 , C12N9/80 , G01N33/569 , G06F19/00 , G01N33/48 , G01N33/50
CPC分类号： C12N9/93 , A61K38/00 , C07K14/205 , C07K14/21 , C07K14/245 , C07K14/31 , C07K14/3156 , C07K2299/00 , C07K2319/00 , C12N9/0006 , C12N9/1077 , C12N9/1085 , C12N9/1205 , C12N9/1217 , C12N9/1229 , C12N9/1241 , C12N9/80 , C12Y207/01026 , C12Y207/01069 , C12Y207/02003 , C12Y207/07003 , C12Y601/01001 , C12Y601/0101 , C12Y601/01021 , G01N33/56911 , G01N33/56938 , G01N33/56944
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
公开(公告)号：US20050164363A1
公开(公告)日：2005-07-28
申请号：US10903476
申请日：2004-07-30
申请人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Simon Houston , Matthew Kimber
发明人： Aled Edwards , Akil Dharamsi , Masoud Vedadi , Simon Houston , Matthew Kimber
CPC分类号： C07K7/06 , C07K7/08 , C07K14/315 , C07K2299/00 , C12N9/88 , C12Y202/01006
摘要： The present invention relates to novel drug targets for pathogenic bacteria. Accordingly, the invention provides purified protein comprising the amino acid sequence set forth in SEQ ID NO: 4. The invention also provides biochemical and biophysical characteristics of the polypeptides of the invention.
摘要翻译： 本发明涉及病原菌的新型药物靶标。 因此，本发明提供了包含SEQ ID NO：4所示氨基酸序列的纯化蛋白质。本发明还提供本发明多肽的生物化学和生物物理学特征。
-
-
-
-
-
-
-
-
-
搜索结果
21 条记录 (耗时 0.043 秒)
